Related Experiment Video
Updated: Jul 31, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Topical phenylephrine for the treatment of middle ear effusion
Insights
Phenylephrine hydrochloride nasal spray and nose drops did not hasten middle ear effusion resolution in children. The study found similar cure rates between medication and placebo groups, suggesting limited efficacy for topical decongestants in this condition.
Area of Science:
- Pediatrics
- Otolaryngology
- Clinical Pharmacology
Background:
- Middle ear effusion (MEE) is a common complication following acute otitis media in children.
- Persistent MEE can lead to hearing impairment and speech delays.
- Topical decongestants are sometimes considered for MEE treatment, but their efficacy is not well-established.
Purpose of the Study:
- To evaluate the efficacy of phenylephrine hydrochloride nasal drops or spray in accelerating the resolution of MEE in children.
- To compare clinical and tympanometric cure rates between phenylephrine hydrochloride and placebo treatments.
Main Methods:
- A randomized, controlled clinical trial was conducted with 152 children experiencing persistent MEE.
- Participants received either phenylephrine hydrochloride nasal spray/drops or a placebo.
- Outcomes were assessed over a four-week period, monitoring clinical signs and tympanometry.
Main Results:
- A significant number of participants (30% and 18%) dropped out or were excluded due to intolerance or intercurrent conditions.
- Among children who completed the study, no significant difference in clinical or tympanometric cure rates was observed between the phenylephrine hydrochloride and placebo groups.
- Administration of nasal drops and spray proved difficult for many pediatric patients.
Conclusions:
- Phenylephrine hydrochloride nasal preparations demonstrated no significant clinical efficacy in hastening the resolution of middle ear effusion in children.
- Practical challenges in administration and lack of proven benefit suggest a limited role for topical decongestants in managing pediatric MEE.
- Further research may be needed to explore alternative or adjunctive treatments for persistent middle ear effusion.
Abstract:
One hundred fifty-two children were enrolled in a randomized, controlled clinical trial of the efficacy of phenylephrine hydrochloride nose drops or nasal spray in hastening the resolution of middle ear effusion. Children with persistent effusion were recruited for the study during a return visit two weeks after an episode of acute otitis media. Forty-six patients (30%) dropped out of the study, many because they failed to tolerate the medication, especially the nose drops. Another 27 (18%) had to be excluded because of intercurrent illness or systemic drug therapy. Among those children completing the study, rates of clinical and tympanometric cure during the following four weeks were similar in the drug and placebo groups. In view of the absence of documented clinical efficacy and the practical difficulties inherent in their administration, topical decongestants appear to have a limited role, if any, in treating children with persistent effusion.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

